{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:52:46Z","timestamp":1777909966015,"version":"3.51.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Dry eye disease (DED) is classified as aqueous deficient, evaporative, or mixed. We investigated the therapeutic effect of the novel anti-inflammatory drug phosphosulindac (PS) in rabbit models of DED encompassing its pathogenesis, and its transition to chronicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We treated three rabbit models of DED with PS (hydrogel formulation) or vehicle topically applied 1\u2009\u00d7\u2009\/day. We induced aqueous-deficient DED (acute and chronic) by injecting Concanavalin A into lacrimal glands; evaporative DED by injecting into the upper eyelid inactivated\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      in complete Freund's adjuvant; and mixed DED through desiccative stress, induced by holding open the eye for 3\u2009h. We determined corneal sensitivity, tear break-up time (TBUT), Schirmer's tear test (STT), tear osmolality, and fluorescein staining of the ocular surface.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>PS reversed all abnormal DED parameters. In acute DED, PS dose dependently normalized corneal sensitivity and tear osmolality; and improved TBUT, STT, and fluorescein staining. PS normalized corneal sensitivity and improved all other parameters in chronic aqueous-deficient DED. In evaporative DED, PS normalized corneal sensitivity and improved TBUT and fluorescein staining (osmolality and STT were not significantly changed in this model). In the desiccative stress model, PS improved TBUT and fluorescein staining but had no effect on STT or tear osmolality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PS rapidly reversed almost all DED parameters in its three subtypes. The normalization of the suppressed corneal sensitivity suggests the possibility of marked symptomatic relief by PS. The hydrogel formulation allows once-daily dosing. PS merits further development as a potential treatment for DED.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jop.2021.0050","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T09:26:15Z","timestamp":1640769975000},"page":"102-113","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical Subtypes"],"prefix":"10.1177","volume":"38","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."},{"name":"Department of Ophthalmology, 2nd Xiangya Hospital, Central South University, Changsha, Hunan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Family, Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Family, Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Sait","family":"Saglam","sequence":"additional","affiliation":[{"name":"Department of Family, Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tourmouzis","sequence":"additional","affiliation":[{"name":"Barts and The London School of Medicine and Dentistry, London, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanford M.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Medicon Pharmaceuticals, Inc., Setauket, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Master","sequence":"additional","affiliation":[{"name":"Department of Family, Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Honkanen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1758-6939","authenticated-orcid":false,"given":"Basil","family":"Rigas","sequence":"additional","affiliation":[{"name":"Department of Family, Population, Preventive Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1407936"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000042"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.07.010"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.029"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0681-1"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.01.010"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-315747"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2018.04.002"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.084657"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.12.057"},{"key":"e_1_3_3_12_2","author":"Honkanen R.A.","year":"2020","unstructured":"Honkanen R.A., , Huang L., , and Rigas B. Arabbit model of aqueous-deficient dry eye disease induced by concanavalin a injection into the lacrimal glands: application to drug efficacy studies. J. Vis. Exp. 2020 [Epub ahead of print]; DOI: 10.3791\/59631.","journal-title":"J. Vis. Exp"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/vision1010010"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2019.1594933"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3791\/60126"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137186"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.1.27"},{"key":"e_1_3_3_18_2","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes","volume":"21","author":"Lemp M.A.","year":"1995","unstructured":"Lemp M.A. Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 21:221\u2013232, 1995.","journal-title":"CLAO J"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.8.6.34"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12075"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/vop.12386"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.4314\/ovj.v7i3.9"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1955.10501294"},{"key":"e_1_3_3_24_2","volume-title":"The Design and Analysis of Clinical Experiments","author":"Fleiss J.L.","year":"1986","unstructured":"Fleiss J.L. The Design and Analysis of Clinical Experiments. New York, NY: Wiley & Sons; 1986."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/75.4.800"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27492008000700014"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.011"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2016.06.002"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2018-000254"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17128-0"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2007.02.002"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"3964642","DOI":"10.1155\/2016\/3964642","article-title":"Evaluating the functionality of conjunctiva using a rabbit dry eye model","volume":"2016","author":"Ning Y.","year":"2016","unstructured":"Ning Y., , Bhattacharya D., , Jones R.E., et al. Evaluating the functionality of conjunctiva using a rabbit dry eye model. J. Ophthalmol. 2016:3964642, 2016.","journal-title":"J. Ophthalmol"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254036"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S126668"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2019.0060"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.001"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100100054027"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.12.018"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70299-9"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307415"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2013.859274"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2013.06.001"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2014.11.001"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7231"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2689"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.19-27802"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1326"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.1998.760113.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/2515841418794886"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62583-x"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(04)80071-1"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.002"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12898"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.01.004"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2009.11.002"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2009.02.012"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.19-26914"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181acf68d"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10817"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2012.683508"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2021.0050","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2021.0050","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2021.0050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:44:38Z","timestamp":1777646678000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2021.0050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,1]]}},"alternative-id":["10.1089\/jop.2021.0050"],"URL":"https:\/\/doi.org\/10.1089\/jop.2021.0050","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}